Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription 20.07.2026 1 AIDS 1 AIDS Res Hum Retroviruses 1 Antimicrob Agents Chemother 1 BMC Cancer 4 Clin Infect Dis 1 HIV Med 1 Int J Cancer 1 Int J Dermatol 6 J Acquir Immune Defic Syndr 1 J Clin Invest 4 J Infect Dis 1 Lancet 1 Lancet Infect Dis 1 Nat Med 9 PLoS One 5 PLoS Pathog 1 Proc Natl Acad Sci U S A 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. OKELLO S, Graff M, Justice AE, Howard AG, et al
   Methylation patterns linked to blood pressure in people with HIV exposed to ART reveal neurovascular and immune pathways: The MACS/WIHS Combined Cohort Study.
   AIDS. 2026 Jun 16. doi: 10.1097/QAD.0000000000004569.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

2. CHEN M, Chen H, Ma Y, Ding W, et al
   Sequence Notes: Identification of a Novel HIV-1 Circulating Recombinant Form (CRF200_0755) in a Southern Border Region of Yunnan, China.
   AIDS Res Hum Retroviruses. 2026 Jul 10:8892229261469040.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

3. VAN DYK J, Waitt C, Mugerwa H, Wiesner L, et al
   Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV.
   Antimicrob Agents Chemother. 2026 Jul 17:e0059226. doi: 10.1128/aac.00592.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. ARIZPE A, Nieva J, Pickering TA, Liu L, et al
   Eligibility criteria and study phase limit racial/ethnic enrollment in oncology clinical trials.
   BMC Cancer. 2026;26:850.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

5. GERETTI AM, Wang K, Leverette B, Hove K, et al
   Impact of HIV-1 RNA Assay Selection on Low-Level Viremia and Clinical Trial Endpoint Interpretations.
   Clin Infect Dis. 2026 Jul 16:ciag435. doi: 10.1093.
   PubMed         Abstract available
   
   
6. MARTIN NK, Chaillon A, Vickerman P, MacGregor L, et al
   Optimizing HCV Screening to Maximize Health Benefit Among Men Who Have Sex with Men in the United States: A Cost-Effectiveness Analysis.
   Clin Infect Dis. 2026 Jul 15:ciag416. doi: 10.1093.
   PubMed         Abstract available
   
   
7. HUANG YS, Sun HY, Lin KY, Huang SH, et al
   Birth in the neonatal HBV vaccination era and hepatitis B surface antigen seroclearance in people with HIV and HBV coinfection on tenofovir-containing antiretroviral therapy.
   Clin Infect Dis. 2026 Jul 11:ciag429. doi: 10.1093.
   PubMed         Abstract available
   
   
8. DA SILVA J, Tejan M, Pals S, Kalata N, et al
   Correlates of Dolutegravir Resistance in Low- and Middle-Income Countries: A Combined Analysis of Drug Resistance Surveys in Four Countries.
   Clin Infect Dis. 2026 Jul 11:ciag427. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   HIV Med

9. KHOEI A, Edmonds A, Chang Y, Ramirez C, et al
   Dolutegravir population pharmacokinetics in racially, sex- and age-diverse and antiretroviral therapy-experienced adults with HIV in the United States.
   HIV Med. 2026 Jul 17. doi: 10.1111/hiv.70278.
   PubMed         Abstract available
   
   

   
   Int J Cancer

10. DEBEAUDRAP P, Kabore FN, Setha L, Tegbe J, et al
    Follow-Up and Outcomes After Thermal Ablation Treatment Among HIV-Infected Women From Resource-Limited Countries With Positive HPV-Based Screening: Results of the AIMA-CC Cohort (ANRS 12375).
    Int J Cancer. 2026 Jul 15. doi: 10.1002/ijc.70648.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

11. TARTAGLIA J, Ponzano M, Sernicola A, Mazzetto R, et al
    Nodular Secondary Syphilis: Systematic Review of an Underrecognized Clinical Phenotype.
    Int J Dermatol. 2026 Jul 12. doi: 10.1111/ijd.70566.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

12. TRAM KH, Sherwood J, Mahaka I, Cameron M, et al
    Projected Impact of U.S. PEPFAR Withdrawal on Zimbabwe and Implications for the Global HIV Response.
    J Acquir Immune Defic Syndr. 2026 Jul 7. doi: 10.1097/QAI.0000000000003925.
    PubMed         Abstract available
    
    
13. HUGHES CS, Brown J, Murombedzi C, Chirenda T, et al
    Cost-effectiveness of safer conception strategies for HIV-discordant couples in Zimbabwe.
    J Acquir Immune Defic Syndr. 2026 Jul 7. doi: 10.1097/QAI.0000000000003926.
    PubMed         Abstract available
    
    
14. EL-IMAM IA, Koudjra AR, Nampota-Nkomba N, Mkandawire F, et al
    Adverse Birth Outcomes Associated with SARS-CoV-2 Infection Among Pregnant Women with and without HIV: A Longitudinal Cohort Study.
    J Acquir Immune Defic Syndr. 2026 Jul 7. doi: 10.1097/QAI.0000000000003924.
    PubMed         Abstract available
    
    
15. VANNAPPAGARI V, Albano JD, Mofenson L, Ragone L, et al
    Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir: Findings From the Antiretroviral Pregnancy Registry.
    J Acquir Immune Defic Syndr. 2026 Jul 7. doi: 10.1097/QAI.0000000000003927.
    PubMed         Abstract available
    
    
16. GUILLAUME D, Olson S, Dionne JA, Alcaide ML, et al
    Prevalence and predictors of abnormal cervical cytology among women living with HIV and without HIV from the MACS/WIHS combined cohort study.
    J Acquir Immune Defic Syndr. 2026 Jul 7. doi: 10.1097/QAI.0000000000003928.
    PubMed         Abstract available
    
    
17. HERTZ JT, Rahim F, Wang C, Vaidyanathan A, et al
    Optimizing Antihypertensive Care for Tanzanians Living With HIV: Effectiveness Outcomes From the COACH Pilot Trial.
    J Acquir Immune Defic Syndr. 2026;101:896-906.
    PubMed         Abstract available
    
    

    
    J Clin Invest

18. MOYSI E, Sharma AA, O'Dell S, Georgakis S, et al
    A favorable follicular helper CD4 T cell programming characterizes neutralization activity in chronic HIV infection.
    J Clin Invest. 2026 Jul 14:e192575. doi: 10.1172/JCI192575.
    PubMed         Abstract available
    
    

    
    J Infect Dis

19. PENG Q, Wong YC, Cheng WY, He Y, et al
    Safety and Immunogenicity of a PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Trial in People With HIV-1 on Antiretroviral Therapy.
    J Infect Dis. 2026 Jul 14:jiag320. doi: 10.1093.
    PubMed         Abstract available
    
    
20. VIMONPATRANON S, Ssemaganda A, Phuang-Ngern Y, Sajjaweerawan C, et al
    Impact of early antiretroviral treatment on tissue resident memory CD4+ T cells in the gastrointestinal tract.
    J Infect Dis. 2026 Jul 16:jiag358. doi: 10.1093.
    PubMed         Abstract available
    
    
21. WOHL DA
    Do They, or Don't They? Integrase Strand Transfer Inhibitors, Tenofovir Alafenamide, and Excessive Weight Gain in People with HIV.
    J Infect Dis. 2026 Jul 16:jiag365. doi: 10.1093.
    PubMed        
    
    
22. LE GUILLOU AV, Marcus JL, Krakower DS, Violette LR, et al
    Potential Risks and Benefits of Low-Barrier Access and Monitoring for HIV Preexposure Prophylaxis: A Modeling Study.
    J Infect Dis. 2026 Jul 17:jiag369. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet

23. MORALEDA C, Tagarro A, Dominguez-Rodriguez S, Musiime V, et al
    Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trial.
    Lancet. 2026 Jul 17:S0140-6736(26)00754-3. doi: 10.1016/S0140-6736(26)00754.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

24. KELLY JD, Peluso MJ
    Towards a long COVID prevention agenda.
    Lancet Infect Dis. 2026 Jul 16:S1473-3099(26)00361.
    PubMed        
    
    

    
    Nat Med

25. FERRAND RA, Dauya E, Chikwari CD, Bandason T, et al
    Author Correction: Integrated community-based HIV and sexual and reproductive health services for youth: a cluster-randomized trial.
    Nat Med. 2026 Jul 16. doi: 10.1038/s41591-026-04581.
    PubMed        
    
    

    
    PLoS One

26. RODRIGUES RL, da Silva-Januario ME, Apolloni VB, Espada CE, et al
    HIV-1 Nef inhibits the JAK/STAT signaling pathway by inducing proteasomal degradation of STAT1.
    PLoS One. 2026;21:e0352649.
    PubMed         Abstract available
    
    
27. STUART A, Horst C, Mullen D, Lowndes C, et al
    Barriers and facilitators to hepatitis C patient engagement: Interview study with general practitioner champions in England.
    PLoS One. 2026;21:e0337867.
    PubMed         Abstract available
    
    
28. MWALUKUNGA LJ, Vincent Moshi F, Kibusi SM
    Preferences for accessing sexual and reproductive health information and services among adolescent girls and young women in higher learning institutions in Tanzania: A qualitative study.
    PLoS One. 2026;21:e0352671.
    PubMed         Abstract available
    
    
29. PEREZ MOLINA CJ, Chavarro Bermeo FE, Perez Hernandez AMB
    Immunoprevention and immunomodulation of yellow fever: A scoping review of global and Latin American evidence.
    PLoS One. 2026;21:e0352755.
    PubMed         Abstract available
    
    
30. AEMRO A, Zegeye AF, Mekonen EG, Wassie YA, et al
    Lifetime HIV testing frequency among women in Sub-Saharan Africa: A DHS-based analysis using zero-inflated negative binomial regression.
    PLoS One. 2026;21:e0354020.
    PubMed         Abstract available
    
    
31. ZURASHVILI T, Pashalishvili M, Abutidze A, Evelene F, et al
    Using nominal group technique to select an HIV status disclosure decision aid for adaptation in Georgia.
    PLoS One. 2026;21:e0353949.
    PubMed         Abstract available
    
    
32. HTUN NL, Mon MM, Thant KS, Kyaw PP, et al
    Chemsex among men who have sex with men (MSM) in Yangon, Myanmar: Prevalence, practices, and associated risk factors.
    PLoS One. 2026;21:e0353993.
    PubMed         Abstract available
    
    
33. INOUE CA, Domingues TSP, Sucupira MCA, Sitnik R, et al
    The epidemiology of the viral hepatitis in Brazil: A scoping review.
    PLoS One. 2026;21:e0353840.
    PubMed         Abstract available
    
    
34. TEREFE B, Derseh NM, Ayele TA
    Geographic inequalities in HIV testing uptake among young women in sub-Saharan Africa: A hierarchical bayesian spatial analysis.
    PLoS One. 2026;21:e0353117.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

35. PIOTROWSKI SL, Li X, Fitzpatrick CE, Tucker A, et al
    Callitrichine herpesvirus 3 in the common marmoset is a model of Epstein-Barr virus infection and associated lymphoma.
    PLoS Pathog. 2026;22:e1014450.
    PubMed         Abstract available
    
    
36. RUIJTEN SDE, Dos Santos JC, Rios-Vazquez V, Navas A, et al
    Co-regulation of HIV control and cytomegalovirus pp65-specific IL-1beta and TNF-alpha responses by genetic variants in the MHC region.
    PLoS Pathog. 2026;22:e1014355.
    PubMed         Abstract available
    
    
37. GRANT HE, Olabode AS, Seiler Vellame D, Poon AFY, et al
    Pervasive HIV recombination limits the utility of circulating recombinant form nomenclature.
    PLoS Pathog. 2026;22:e1014286.
    PubMed         Abstract available
    
    
38. DHUMMAKUPT A, McFarland AG, Szewczyk J, Everett J, et al
    Quantification and localization of integrated HIV-1 in memory and naive CD4+ T cells from adolescents and young adults with perinatally-acquired HIV-1.
    PLoS Pathog. 2026;22:e1014369.
    PubMed         Abstract available
    
    
39. MAHDI M, Lakatos B, Motyan JA, Hoffka G, et al
    HIV capsid inhibitors: Mechanisms, resistance, and therapeutic advances.
    PLoS Pathog. 2026;22:e1014361.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

40. CHO SY, Rantalainen K, Ozorowski G, Lu D, et al
    Structural basis of membrane engagement and polyreactivity control in HIV-1 MPER broadly neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2026;123:e2609827123.
    PubMed         Abstract available
    
    

    
    Vaccine

41. AUNG TN, Muyindike W, Hoeppner SS, Nanfuka V, et al
    COVID-19 vaccination among people with HIV in Uganda: lessons from a high-risk group with high vaccine uptake for the next pandemic.
    Vaccine. 2026;88:128912.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum